Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537252 | Vaccine | 2017 | 6 Pages |
Abstract
Study findings suggest that persons with previous exposure to Ad5 may be systematically different from their Ad5-negative peers. Unprotected anal sex with a casual partner significantly decreased among HIV vaccine trial participants, as did HIV worry and perceived chance of getting HIV. Findings did not support evidence of risk compensation among HIV vaccine trial participants compared to Ad5+ participants.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Julia E. Painter, Ralph J. DiClemente, Lauren Jimenez, Theron Stuart, Jessica M. Sales, Mark J. Mulligan,